These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38808878)

  • 1. Minimum sample size for estimating the Net Promoter Score under a Bayesian approach.
    Costa EG; Ponte RTQ
    An Acad Bras Cienc; 2024; 96(2):e20230991. PubMed ID: 38808878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Net Promoter Score (NPS) for Insight Into Client Experiences in Sexual and Reproductive Health Clinics.
    Koladycz R; Fernandez G; Gray K; Marriott H
    Glob Health Sci Pract; 2018 Oct; 6(3):413-424. PubMed ID: 30072372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The one number you need to grow.
    Reichheld FF
    Harv Bus Rev; 2003 Dec; 81(12):46-54, 124. PubMed ID: 14712543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customer churn prediction for telecommunication industry: A Malaysian Case Study.
    Mustafa N; Sook Ling L; Abdul Razak SF
    F1000Res; 2021; 10():1274. PubMed ID: 35528953
    [No Abstract]   [Full Text] [Related]  

  • 5. Bayesian techniques for sample size determination in clinical trials: a short review.
    Pezeshk H
    Stat Methods Med Res; 2003 Dec; 12(6):489-504. PubMed ID: 14653352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian sample size calculation for estimation of the difference between two binomial proportions.
    Pezeshk H; Nematollahi N; Maroufy V; Marriott P; Gittins J
    Stat Methods Med Res; 2013 Dec; 22(6):598-611. PubMed ID: 21436190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian sample size determination for case-control studies when exposure may be misclassified.
    Joseph L; Bélisle P
    Am J Epidemiol; 2013 Dec; 178(11):1673-9. PubMed ID: 24036491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPS and Online WOM: Investigating the Relationship Between Customers' Promoter Scores and eWOM Behavior.
    Raassens N; Haans H
    J Serv Res; 2017 Aug; 20(3):322-334. PubMed ID: 29046609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach on sample size calculation for comparing means.
    Wang H; Chow SC; Chen M
    J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-component mixture of Rayleigh distributions: properties and estimation in Bayesian framework.
    Aslam M; Tahir M; Hussain Z; Al-Zahrani B
    PLoS One; 2015; 10(5):e0126183. PubMed ID: 25993475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian sample-size determination for inference on two binomial populations with no gold standard classifier.
    Stamey JD; Seaman JW; Young DM
    Stat Med; 2005 Oct; 24(19):2963-76. PubMed ID: 16007574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimization approach to calculating sample sizes with binary responses.
    Maroufy V; Marriott P; Pezeshk H
    J Biopharm Stat; 2014; 24(4):715-31. PubMed ID: 24697665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian inference for disease prevalence using negative binomial group testing.
    Pritchard NA; Tebbs JM
    Biom J; 2011 Feb; 53(1):40-56. PubMed ID: 21259308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exact sample size determination for a single Poisson random sample.
    Gentile S; Sambucini V
    Biom J; 2023 Oct; 65(7):e2200183. PubMed ID: 37160700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
    Kikuchi T; Pezeshk H; Gittins J
    Stat Med; 2008 Jan; 27(1):68-82. PubMed ID: 17566967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian sample size determination for longitudinal studies with continuous response based on different scientific questions of interest.
    Baghfalaki T
    J Biopharm Stat; 2019; 29(2):244-270. PubMed ID: 30359549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian and mixed Bayesian/likelihood criteria for sample size determination.
    Joseph L; du Berger R; Bélisle P
    Stat Med; 1997 Apr; 16(7):769-81. PubMed ID: 9131764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.